Skip to main content
. Author manuscript; available in PMC: 2020 May 27.
Published in final edited form as: Pharm Res. 2018 Aug 21;35(10):194. doi: 10.1007/s11095-018-2473-7

Table 5:

Mean (SD) in vitro aerosol drug delivery using the Aerogen Solo Nebulizer with passive nasal inhalation conditions and 8 LPM system flow rate. Values are reported as a percentage of ED. Standard deviations (SD) shown in parenthesis [n=3].

Description Passive Nasal
ED (mg) 2.8 (0.1)
Device (%) 1.7 (0.9)
Tee (%) 52.6 (3.3)
Tubing (%) 29.9 (0.2)
Cannula ED (%) 15.7 (3.8)
NMT (%) 0.0 (0.0)
Filter Delivery (%) 1.4 (0.2)
Recovery (%) 85.7 (4.0)